Document is current
Any future updates will be listed below
-
Authors
Kawada, Tatsushi
Katayama, Satoshi
Yanagisawa, Takafumi
Mori, Keiichiro
Fukuokaya, Wataru
Komura, Kazumasa
Tsujino, Takuya
Maenosono, Ryoichi
Takahara, Kiyoshi
Nukaya, Takuhisa
Inoki, Lan
Toyoda, Shingo
Hashimoto, Takeshi
Hirasawa, Yosuke
Edamura, Kohei
Kobayashi, Tomoko
Bekku, Kensuke
Nishimura, Shingo
Iwata, Takehiro
Sadahira, Takuya
Tominaga, Yusuke
Yamanoi, Tomoaki
Yoshinaga, Kasumi
Tsuboi, Kazuma
Kobayashi, Yasuyuki
Takamoto, Atsushi
Kurose, Kyohei
Kimura, Takahiro
Azuma, Haruhito
Shiroki, Ryoichi
Fujita, Kazutoshi
Ohno, Yoshio
Araki, Motoo
,
- License Information
-
More Information
Article History
Received: 27 February 2025
Accepted: 20 June 2025
First Online: 25 July 2025
Declarations
:
: Kazutoshi Fujita received honorarium from Ono, Bristle, MSD, Eisai, Pfizer, Merk, and Takeda. Takahiro Kimura is a paid consultant/advisor of Astellas, Bayer, Janssen, Sanofi and Takeda. The other authors declare no conflicts of interest associated with this manuscript.
: This study was approved by the ethical review board at Osaka Medical and Pharmaceutical University; approval number: RIN–750–2571 executed in accordance with the principles outlined in the World Medical Association Declaration of Helsinki, with the participants’ informed consent.
